Synapse Medicine: Difference between revisions
Created company page — France |
Added valuation: Series B+; est. ~€50-100M |
||
| Line 11: | Line 11: | ||
== Funding == | == Funding == | ||
'''Valuation:''' Series B+; est. ~€50-100M | |||
Series B+. Backed by BPI France, Elaia Partners. | Series B+. Backed by BPI France, Elaia Partners. | ||
Revision as of 07:42, 14 April 2026
What They Do
Digital prescription and medication management platform helping healthcare professionals prescribe safely and manage drug interactions.
Funding
Valuation: Series B+; est. ~€50-100M Series B+. Backed by BPI France, Elaia Partners.